Article
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia
28 Dec 2015
Abstract excerpt
Juvenile myelomonocytic leukemia (JMML) is a rare and aggressive stem cell disease of early childhood. RAS activation constitutes the core component of oncogenic signaling. In addition, leukemic blasts in one-fourth of JMML patients present with monosomy 7, and more than half of patients show elevated age-adjusted fetal hemoglobin (HbF) levels. Hematopoietic stem cell transplantation is the current standard of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
